Drug Discovery Market Research, Intelligence and Forecasts

Drug Discovery		email this page print page
Title		Publication Date		Price
Outsourcing in Drug Discovery, 3rd Edition		May 2008		£1765
Blood Cancer Drug Discoveries What the Future Holds		April 2008		£1295
Drug Approval Trends at the FDA and EMEA Process Improvements, Heightened Scrutiny and Industry Response		April 2008		£1995
Live-Licensing & In-life Testing R&D Processes and Regulation for New Drugs, 2008-2020		January 2008		£1499
Gastrointestinal Drug Discoveries		January 2008		£995
Premium Company Profile: Acambis PLC		November 2007		£265
Combating Generics 2008 Counter-Generics Strategy, Tactics and Execution		October 2007		£3885
Drug Development Opportunities In China Regulation, Key Players And Initiatives For Domestic And International Markets		September 2007		£1495
Drug Discovery Tools for High-Content Analysis		July 2007		£990
Preparing the Common Technical Document (CTD) for CMC		March 2007		£4950
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery Equipment, Technologies and Companies, 2006-2011		January 2007		£815
Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target Space		January 2007		£2675
Current Drug Development Market for Cytokines, Chemokines and Growth Factors		January 2007		£2600
Discovery to IND Filing 2nd Edition		January 2007		£520
Novel Targets in Drug Discovery		November 2006		£2605
CNS Drug Discoveries: Multiple Sclerosis		November 2006		£795
CNS Drug Discoveries: Depression		November 2006		£795
CNS Drug Discoveries: Neurodegenerative Disorders		November 2006		£795
CNS Drug Discoveries: Sleep Disorders		November 2006		£795
CNS Drug Discoveries What the Future Holds		November 2006		£1995
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues Revised Edition		October 2006		£2750
Impact of Nano Materials in Drug Delivery & Human Tissue Engineering		October 2006		£2750
Kinases		September 2006		£2750
Managing Toxicology for the Future Improving Predictive Power Through Integrated Technologies, 2nd Edition		August 2006		£2750
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Quantitative Analysis		August 2006		£2750
Plant-Derived Drugs: Products, Technology, Applications		June 2006		£2410
COPD Drug Discovery How New Generation Therapies Seek to Target Underlying Disease		June 2006		£2750
Transmembrane Transporters High Sales, High Potential as Drug Targets		June 2006		£2750
Cardiovascular Drug Discoveries What the Future Holds		May 2006		£1995
Contract Drug Discovery Industry Sector Snapshot		March 2006		£250
Drug Repositioning A market analysis		March 2006		£1095
Cell Therapy Commercialization Applying Stem Cell and Related Strategies		January 2006		£2750
How to Succeed In Personalized Medicine by Using Tools and Technologies Which Companies and Technologies are Profiting From a Favorable Regulatory Environment		January 2006		£2750
Guide to Discovery to IND Filing, A		December 2005		£440
Market Opportunities and Challenges for Antibody Arrays and Beads A Market Research Study		November 2005		£1665
Organic and Medicinal Chemistry in Drug Discovery		November 2005		£2750
RNAi Therapeutics Challenges in Drug Development and Delivery		November 2005		£1945
Patents in the Postgenomic Era Proprietary Drug Targets and Therapies		October 2005		£2750
hERG Technology and Market Analysis		October 2005		£1665
ADME in Children and The Elderly Clinical Challenges and Opportunities		October 2005		£2750
Combination Therapies Benefits and Challenges in Drug, Device, and Biologicals Development		October 2005		£1945
Cancer Drug Discoveries What the Future Holds		August 2005		£1995
Powering Discovery through Target Evaluation Moving Beyond the Validation Paradigm		August 2005		£1950
Phosphodiesterases A Drug Target Family with Broad Therapeutic Impact		August 2005		£2750
Model Organisms in Drug Discovery and Development An Industry Analysis		June 2005		£1665
Event Analysis and Response Service: Cox-2s Cox-2 Crisis Dents Big Pharma Confidence		June 2005		£6000
Industrialization of Drug Discovery		May 2005		£80
Angiogenesis Modulators Strategies for Drug Discovery		May 2005		£2750
Rapid Viral Testing		April 2005		£2750
Impact of Nanotechnology in Drug Discovery, The		April 2005		£1665
Impact of Nanotechnology in Drug Discovery; The		March 2005		£1140
Virtual Screening in Drug Discovery		March 2005		£85
Cancer Vaccines Fantasy or Future?		February 2005		£1325
Solving Drug Discovery with Metabolomics and Metabonomics New Aspects of the "Omic" Revolution		February 2005		£2750
Proteases as Drug Targets		January 2005		£2750
Ethical Issues in Drug Development		January 2005		£220
The Outlook For RNAi Accelerating drug discovery and the development of RNAi therapeutics		January 2005		£1495
Emerging Drug Discovery Technologies Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi		January 2005		£1495
Protein- Protein Interactions as Drug Targets Focusing on Cell Circuitry		January 2005		£1665
RNAi: Broad Application, Expansive Opportunity 2nd Edition		January 2005		£1385
Structure-Guided Drug Design Rediscovering the Importance of Drug Structure for Drug Discovery		November 2004		£1940
Antibody Therapeutics Product Development, Market Trends, and Strategic Issues, 2nd Edition		September 2004		£2750
Fluorescent Proteins Technologies, Applications, and Opportunities for Drug Discovery		August 2004		£1660
Tissue MicroArrays Emerging Business Opportunities and Applications Driving the Marketplace		August 2004		£2750
Migraine A market focus		August 2004		£885
Chemical Genomics Commercial Applications in Drug Discovery and Development		July 2004		£1660
Pharmaceutical Discovery & Development Report		June 2004		£185
Model Animal Systems Emerging Applications and Commercial Opportunities in Drug Discovery and Development		June 2004		£1946
Ion Channel Drug Discovery Therapeutic Opportunities & Technology Progress		May 2004		£680
Cell Signalling Pathways Productive Sources of Pharmaceutical Targets		May 2004		£2750
Peptide Therapeutics Applications in the Treatment of Human Diseases		April 2004		£1660
Novel Targets in Drug Discovery A new era in therapy		April 2004		£595
Part 11 and Drug Development A Q&A Reference Guide (March, 2004)		March 2004		£15
Metabolic Syndrome New Opportunities in Diagnostics and Therapeutics		February 2004		£2750
Phosphatases Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets		February 2004		£1660
Systems Biology Key to Unlocking the Value within the Omics Revolution		January 2004		£1660
Stephens' Detection of New Adverse Drug Reactions 5th Edition		December 2003		£110
Cytokines, Chemokines, and Growth Factors Key Targets for Immunotherapeutic Development		December 2003		£2750
Lead Optimization A Reinvention of the Process		November 2003		£1670
Drug Discovery Strategies and Methods		November 2003		£100
Nuclear Receptors Key Targets for New Pharmaceuticals		November 2003		£2750
Rheumatoid Arthritis: Emerging drug discovery targets And therapeutic candidates		October 2003		£375
Post-Genomic Biomarkers Revolutionizing Drug Development and Diagnostics		October 2003		£2750
Asthma Therapeutics New treatment options and emerging drug discovery targets		April 2003		£330
Burger's Medicinal Chemistry and Drug Discovery 6 Volume Set		March 2003		£1331
Worldwide Drug Discovery R&D Current Status, Clinical Pipeline, and Analysis		November 2001		£545
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development		August 2001		£815
Drug Discovery Technology A Combination Of Opportunities		June 2001		£2410
The US Bio-Chip Market for Pharmaceutical Drug Discovery Technology, Strategic Alliance, Patent Dispute and Market Update - 2002		May 2001		£545
Post Genome Project Era Proteomics R&D Competition		January 2001		£815
Drug Development Programme Management		October 2000		£140